JPND SYMPOSIUM 2024
From air pollution to brain pollution – novel biomarkers to unravel the link of air pollution and Alzheimer’s disease.
Coordinator: Katja Kanninen, University of Eastern Finland, Finland.
Project pitch by Tarja Malm.
Personalised medicine approach for novel microglia-associated genetic variants in Alzheimer’s disease.
Coordinator: Mikko Hiltunen, University of Eastern Finland (UEF), Finland.
Project pitch by Mikko Hiltunen.
Defining measures of proximity to symptom onset in the GENetic Frontotemporal dementia Initiative.
Coordinator: Jonathan Rohrer, University College London, United Kingdom.
Project pitch by Arabella Bouzigues.
Diagnostic and prognostic precision medicine for behavioral variant frontotemporal dementia.
Coordinator: Yolande Pijnenburg, Amsterdam University Medical Center, The Netherlands.
Project pitch by Sterre de Boer.
Identifying and treating SORL1-associated Alzheimer’s disease.
Coordinator: Henne Holstege, Stichting VUmc (VU University Medical Center),The Netherlands.
Project pitch by Henne Holstege.
Music Interventions for Dementia and Depression in ELderly care (MIDDEL): International cluster-randomised trial.
Coordinator: Christian Gold, NORCE Norwegian Research Centre AS, Norway.
Project pitch by Christian Gold.
Precision Medicine Interventions in Alzheimer’s Disease.
Coordinator: Tormod Fladby, University of Oslo, Norway.
Project pitch by Tormod Fladby.
GBA – personalised medicine for Parkinson disease: clinical and therapeutic Stratification.
Coordinator: Anthony H.V. Schapira, University College London, United Kingdom.
Project pitch by Marco Toffoli.
From air pollution to brain pollution – novel biomarkers to unravel the link of air pollution and Alzheimer’s disease.
Coordinator: Katja Kanninen, University of Eastern Finland, Finland.
Project pitch by Tarja Malm.
Personalised medicine approach for novel microglia-associated genetic variants in Alzheimer’s disease.
Coordinator: Mikko Hiltunen, University of Eastern Finland (UEF), Finland.
Project pitch by Mikko Hiltunen.
Defining measures of proximity to symptom onset in the GENetic Frontotemporal dementia Initiative.
Coordinator: Jonathan Rohrer, University College London, United Kingdom.
Project pitch by Arabella Bouzigues.
Diagnostic and prognostic precision medicine for behavioral variant frontotemporal dementia.
Coordinator: Yolande Pijnenburg, Amsterdam University Medical Center, The Netherlands.
Project pitch by Sterre de Boer.